Summary
In a previous study we demonstrated that the kidney content of somatomedin C was maximal one to two days after uninephrectomy or induction of diabetes, and that insulin treatment prevented an increase in kidney somatomedin C as well as kidney growth in diabetic animals. In the present study we ave examined the effect of a somatostatin analogue on kidney somatomedin C and initial renal growth in the two experimental situations. The kidney hypertrophy in untreated diabetic animals amounted to 23% four days after streptozotocin injection and followed an increase in kidney somatomedin C content of 60% reaching the maximum after 48 h. In young and old uninephrectomized rats kidney growth was 19% and 16% after four days. In young animals a prompt increase of 50% in kidney somatomedin C was seen as reaching the maximum after 24 h, while the somatomedin C content in kidneys from old animals was maximal after 48 h (increase of 58%) in good accordance with the slightly slower kidney growth. The new findings of the present study are that administration of a long-acting somatostatin analogue (Sandostatin) effectively prevented the obligatory increase in kidney somatomedin C content as well as kidney growth both in experimental diabetes and after uninephrectomy. It is noteworthy that Sandostatin administration did not alter the metabolic state in diabetic animals indicating that the inhibition of kidney hypertrophy could not be attributed to improved metabolic control. The results thus support the concept that somatomedin C is involved in initial diabetic and post-nephrectomy renal growth.
Article PDF
Similar content being viewed by others
References
Seyer-Hansen K (1983) Renal hypertrophy in experimental diabetes mellitus. Kidney Int 23: 643–646
Flyvbjerg A, Thorlacius-Ussing O, Næraa R, Ingerslev J, Ørskov H (1988) Kidney tissue somatomedin C and initial renal growth in diabetic and uninephrectomized rats. Diabetologia 31: 310–314
Mogensen CE (1982) Diabetes mellitus and the kidney. An introduction. Kidney Int 21: 673–675
Fine L (1986) The biology of renal hypertrophy. Kidney Int 29: 619–634
Stiles AD, Sosenko IRS, D'Ercole AJ, Smith BJ (1985) Relations of kidney tissue somatomedin-C/insulin-like growth factor I to postnephrectomy renal growth in the rat. Endocrinology 117: 2397–2401
Fagin JA, Melmed S (1987) Relative increase in insulin-like growth factor I messenger ribonucleic acid levels in compensatory renal hypertrophy. Endocrinology 120: 718–724
Anderson GL, Skottner A, Jennische E (1988) Immunocytochemical and biochemical localization of insulin-like growth factor I in the kidney of rats before and after uninephrectomy. Acta Endocrinol (Copenh) 119: 555–560
Vora J, Owens DR, Luzio S, Atiea J, Ryder R, Hayes TM (1987) Renal response to intravenous somatostatin in insulin-dependent diabetic patients and normal subjects. J Clin Endocrinol Metab 64: 975–979
Christensen SE, Pedersen MM, Christiansen JS, Ørskov H, Mogensen CE (1988) Acute effects of the somatostatin analogue SMS 201-995 on kidney function in IDDM. Diab Res Clin Prac 5 [Suppl 1]: S87 [abstract]
Steer KA, Sochor M, Kunjara S, Doepfner W, McLean P (1988) The effect of a somatostatin analogue (SMS 201-995, Sandostatin) on the concentration of phosphoribosyl pyrophosphate and the activity of the pentose phosphate pathway in the early renal hypertrophy of experimental diabetes in the rat. Biochem Med Metab Biol 39: 226–233
D'Ercole AJ, Stiles AD, Underwood LE (1984) Tissue concentration of somatomedin C: Further evidence for multiple sites of synthesis and paracrine/autocrine mechanisms of action. Proc Natl Acad Sci USA 81: 935–939
Christensen SE, Weeke J, Ørskov H, Møller N, Flyvbjerg A, Harris AG, Lund E, Jørgensen J (1987) Continuous subcutaneous pump infusion of somatostatin analogue SMS 201-995 versus subcutaneous injection schedule in acromegalic patients. Clin Endocrinol 27: 297–306
Plewe G, Noelken G, Krause U, Beyer J, del Pozo E (1987) Suppression of growth hormone and somatomedin C by longacting somatostatin analogue SMS 201-995 in type I diabetes mellitus. Horm Res 27: 7–12
Grond J, Schilthuis MS, Koudstaal J, Elema JD (1982) Mesangial function and glomerular sclerosis in rats after unilateral nephrectomy. Kidney Int 22: 338–343
Zucchelli P, Cagnoli L, Casanova S, Donini U, Pasquali S (1983) Focal glomeralosclerosis in patients with unilateral nephrectomy. Kidney Int 24: 649–655
Brenner BM, Hostetter TH, Olsen JL, Rennke HG, Venkatachalam MA (1981) The role of glomerular hyperfiltration in the initiation and progression of diabetic nephropathy. Acta Endocrinol (Copenh) 97: [Suppl 242]: 7–10
Mogensen CE (1986) Early glomerular hyperfiltration in insulin-dependent diabetics and late nephropathy. Scand J Clin Lab Invest 46: 201–206
Hansen AaP, Mogensen CE (1972) Growth hormone secretion and kidney function during normalization of the metabolic state in newly diagnosed juvenile diabetes. Horm Metab Res 4: 11–15
Seyer-Hansen K, Gundersen HJG, Østerby R (1981) Acute renal hypertrophy in experimental diabetes: Lack of effect of short-term growth hormone administration. Diabetologia 21: 374–375
Ørskov H (1985) Growth hormone hyperproduction inducing some of the vicious circles in diabetes mellitus. Acta Med Scand 217: 343–346
Robinson ICAF, Clark RG, Carlsson LMS (1987) Insulin, IGF-I and growth in diabetic rats (Letter). Nature 326: 549
Scheiwiller E, Guler H-P, Marryweather J, Scandella C, Maerki W, Zapf J, Froesch ER (1986) Growth restoration of insulin-deficient diabetic rats by recombinant human insulin-like growth factor I. Nature 323: 169–171
Fogelman A, Goldman R (1966) Effects of hypophysectomy and growth hormone on renal compensatory hypertrophy in rats. Proc Soc Exp Biol Med 122: 568–573
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Flyvbjerg, A., Frystyk, J., Thorlacius-Ussing, O. et al. Somatostatin analogue administration prevents increase in kidney somatomedin C and initial renal growth in diabetic and uninephrectomized rats. Diabetologia 32, 261–265 (1989). https://doi.org/10.1007/BF00285295
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00285295